Financials

  • Market Capitalization 12.48 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-35.68
市销率
10.67

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
755
EXEL
Exelixis, Inc. - Common Stock
54.64 USD+0.35%-1.07%+3.82%+39.96%13.54 B USD
791
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
65.23 USD+0.87%+0.31%+7.94%+11.70%12.63 B USD
809
CORT
Corcept Therapeutics Incorporated - Common Stock
113.35 USD-0.47%-9.23%-0.71%+54.49%12.25 B USD
817
HALO
Halozyme Therapeutics, Inc. - Common Stock
106.49 USD+1.08%-2.64%+28.92%+59.42%12.09 B USD

新闻